Global Overactive Bladder Treatment Market 2018-2028 - Visiongain Report

Monday, June 11, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, June 11, 2018 /PRNewswire/ --

Prescription Drugs, OTC Drugs, Short-term Therapy,

Long-term Therapy

The global overactive bladder treatment market is expected to grow at a CAGR of 2.4% in the first half of the forecast period. In 2017, the prescription drugs segment held 96% of the market.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

)

How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 161-page report you will receive 136 charts- all unavailable elsewhere.

The 161-page report provides clear detailed insight into the global overactive bladder treatment market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Global Overactive Bladder Treatment market forecasts from 2018-2028

 This report also breaks down the revenue forecast for the global overactive bladder treatment market by these submarkets: • Prescription Drugs Market Forecast 2018-2028 • OTC Drugs Market Forecast 2018-2028 • Short-term Therapy Market Forecast 2018-2028 • Long-term Therapy Market Forecast 2018-2028

 This report provides individual revenue forecasts to 2028 for these regional and national markets: • US • EU5: Germany, France, UK, Italy, Spain • BRIC: Brazil, Russia, India, China Japan • RoW: South Korea, Australia, Canada, MENA, Others

 Our study gives qualitative analysis of the overactive bladder treatment market: • Drivers and Restraints • Porter's Five Forces Analysis • SWOT Analysis • Trends and Opportunities • Reimbursement scenarios in the US, Europe and Japan

• Our study discusses the selected leading companies that are the major players in the overactive bladder treatment market: • Allergan • Apotex • Astellas • Medtronic • Mylan • Pfizer • Sanofi

Visiongain's study is intended for anyone requiring commercial analyses for the global overactive bladder treatment market. You find data, trends and predictions.

Buy our report today Global Overactive Bladder Treatment Market 2018-2028: Prescription Drugs, OTC Drugs, Short-term Therapy, Long-term Therapy.

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website : https://www.visiongain.com/Report/2205/Global-Overactive-Bladder-Treatment-Market-2018-2028

Companies Listed 

Addex Therapeutics Allergan AltheRx Pharmaceuticals American Oriental Bioengineering Amerifit Antares Pharma Apogepha Arzneimittel Apotex Astellas Aventis Bayer Boehringer Ingelheim Catalent Pharma Solutions CSL Eli Lilly Endo international FemmePharma Ferring Pharmaceuticals Galen Ltd Hisamitsu Pharmaceutical Hydra Biosciences Ion Channel Innovations Janssen Kissei Pharmaceutical Co., Ltd. Kwang Dong Pharmaceutical KYORIN Pharma Lipella Pharmaceuticals Matrix Laboratories Limited Medtronic Merck KGaA Merus Labs Luxco S.a.R.L. Mylan Novartis Ono Pharmaceuticals Paddock Laboratories Paladin Pfizer Ranbaxy Laboratories Recordati Pharmaceuticals Ltd Sanofi Sanofi Espoir Foundation Sanofi Synthelabo Schwarz Pharma AG Speciality European Pharma Ltd Warner Chilcott Watson Pharmaceuticals, Inc. Yamanouchi Pharma

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

SOURCE Visiongain



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store